These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 23313066)
1. High-dose chemotherapy and autologous stem cell transplantation for multiple myeloma in HIV-positive patients in the highly active antiretroviral therapy era: the myeloma institute of research and therapy experience. Muzaffar J; Usmani S; Abdallah AO; Anaissie E; Cottler-Fox M; Restrepo A Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):171-4. PubMed ID: 23313066 [No Abstract] [Full Text] [Related]
2. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy. Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469 [TBL] [Abstract][Full Text] [Related]
4. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. Re A; Cattaneo C; Michieli M; Casari S; Spina M; Rupolo M; Allione B; Nosari A; Schiantarelli C; Vigano M; Izzi I; Ferremi P; Lanfranchi A; Mazzuccato M; Carosi G; Tirelli U; Rossi G J Clin Oncol; 2003 Dec; 21(23):4423-7. PubMed ID: 14581441 [TBL] [Abstract][Full Text] [Related]
5. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy. Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801 [TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier. Kentos A; Vekemans M; Van Vooren JP; Lambermont M; Liesnard C; Feremans W; Farber CM Bone Marrow Transplant; 2002 Feb; 29(3):273-5. PubMed ID: 11859402 [TBL] [Abstract][Full Text] [Related]
7. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma. Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951 [TBL] [Abstract][Full Text] [Related]
8. The role of autologous stem cell transplantation in the management of multiple myeloma. Fermand JP; Brechignac S Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889 [TBL] [Abstract][Full Text] [Related]
10. Positive results with autologous transplant of ZFN-modified CD4 T-cells: a step toward a practical, functional cure for HIV. AIDS Patient Care STDS; 2011 Nov; 25(11):693. PubMed ID: 22023317 [No Abstract] [Full Text] [Related]
11. [High-dose chemotherapy with autologous hematopoietic stem cell transplantation for multiple myeloma]. Kosugi H Rinsho Ketsueki; 2015 Mar; 56(3):279-88. PubMed ID: 25876781 [TBL] [Abstract][Full Text] [Related]
12. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. Gabarre J; Marcelin AG; Azar N; Choquet S; Lévy V; Lévy Y; Tubiana R; Charlotte F; Norol F; Calvez V; Spina M; Vernant JP; Autran B; Leblond V Haematologica; 2004 Sep; 89(9):1100-8. PubMed ID: 15377471 [TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of ten symptomatic multiple myeloma patients with HIV infection: a potential therapeutic effect of HAART in multiple myeloma. Li G; Lewis RD; Mishra N; Axiotis CA Leuk Res; 2014 Sep; 38(9):1079-84. PubMed ID: 25064217 [TBL] [Abstract][Full Text] [Related]
14. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation. Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045 [TBL] [Abstract][Full Text] [Related]
15. Dermatomyositis and sarcoid-like reaction associated with multiple myeloma treated effectively by high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Chakraverty R; Rabin N; Peggs K; Robinson S; Duncan JR; Yong K Bone Marrow Transplant; 2001 Jun; 27(11):1215-7. PubMed ID: 11551034 [TBL] [Abstract][Full Text] [Related]
16. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma. Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252 [TBL] [Abstract][Full Text] [Related]
17. Advances in the treatment of multiple myeloma. Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186 [No Abstract] [Full Text] [Related]
18. IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantation. Wechalekar A; Amato D; Chen C; Keith Stewart A; Reece D Ann Hematol; 2005 Feb; 84(2):115-7. PubMed ID: 15503021 [TBL] [Abstract][Full Text] [Related]
19. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation. Pippi F Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707 [TBL] [Abstract][Full Text] [Related]
20. Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma. Patriarca F; Sperotto A; Filì C; Zaja F; Prosdocimo S; Fanin R Haematologica; 2002 Jul; 87(7):779-81. PubMed ID: 12091134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]